Items where Author is "Al-Sarireh, B."
Jump to: 2023 Number of items: 1. 2023Ghaneh, P. and Palmer, D. and Cicconi, S. and Jackson, R. and Halloran, C. M. and Rawcliffe, C. and Sripadam, R. and Mukherjee, S. and Soonawalla, Z. and Wadsley, J. and Al-Mukhtar, A. and Dickson, E. and Graham, J. and Jiao, L. and Wasan, H. S. and Tait, I. S. and Prachalias, A. and Ross, P. and Valle, J. W. and O'Reilly, D. A. and Al-Sarireh, B. and Gwynne, S. and Ahmed, I. and Connolly, K. and Yim, K. L. and Cunningham, D. and Armstrong, T. and Archer, C. and Roberts, K. and Ma, Y. T. and Springfeld, C. and Tjaden, C. and Hackert, T. and Büchler, M. W. and Neoptolemos, J. P. and European Study Group for Pancreatic Cancer, . (2023) Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol, 8 (2). pp. 157-168. |